Pediatric acute dacryocystitis due to Eikenella corrodens: A case report.
Acute Disease
Aggregatibacter
Anti-Bacterial Agents
/ administration & dosage
Cardiobacterium
Cefotaxime
/ administration & dosage
Cephalexin
/ administration & dosage
Child, Preschool
Dacryocystitis
/ diagnosis
Drug Administration Routes
Eikenella corrodens
/ isolation & purification
Female
Gram-Negative Bacterial Infections
/ diagnosis
Haemophilus
Humans
Kingella
Microbial Sensitivity Tests
Tomography, X-Ray Computed
Treatment Outcome
Dacryocystitis
Eikenella corrodens
HACEK
Journal
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
received:
09
10
2019
revised:
17
12
2019
accepted:
18
12
2019
pubmed:
27
1
2020
medline:
11
11
2020
entrez:
27
1
2020
Statut:
ppublish
Résumé
Eikenella corrodens is a facultatively anaerobic gram-negative rod bacterium in the oropharynx and respiratory tract. It is a member of HACEK (Haemophilus spp., Aggregatibacter spp., Cardiobacterium hominis, E. corrodens, and Kingella kingae) group commonly associated with endocarditis and craniofacial infections. It is usually susceptible to penicillin, second and third-generation cephalosporins, and carbapenem, but has variable susceptibility to first-generation cephalosporin. We herein provide a description of the first case of pediatric acute dacryocystitis caused by E. corrodens. The patient did not respond to oral cephalexin and required surgical drainage followed by intravenous cefotaxime. Also provided is a brief review of the current literature.
Identifiants
pubmed: 31982291
pii: S1341-321X(19)30383-6
doi: 10.1016/j.jiac.2019.12.014
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Cefotaxime
N2GI8B1GK7
Cephalexin
OBN7UDS42Y
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
510-512Informations de copyright
Copyright © 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest None.